Commission Delegated Directive (EU) 2026/374 of 20 February 2026 amending Delegated Directive (EU) 2017/593 as regards the conditions for the provision of third-party execution and research services to investment firms that provide portfolio management or other investment or ancillary services

Amends Delegated Directive 2017/593 to reflect the Listing Act change (Directive 2024/2811) that lets investment firms pay for third-party research and execution either jointly or separately; whichever method they use, firms must assess research quality annually against robust criteria and act if it falls short. Transposition and application are aligned with Directive 2024/2811.